Comgest Global Investors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Comgest Global Investors’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-21,026	Closed	-$1.68M	–	57
2018 Q3	$1.68M	Sell	21,026 -222,626	-91%	-$20.7M	0.04%	48
2018 Q2	$24.2M	Sell	243,652 -394,100	-62%	-$34.1M	0.54%	20
2018 Q1	$51.7M	Buy	637,752 +2,000	+0.3%	+$162K	1.13%	18
2017 Q4	$50.1M	Buy	635,752 +279,500	+78%	+$23.2M	1.09%	19
2017 Q3	$32.9M	Buy	356,252 +204,649	+135%	+$19.7M	0.76%	21
2017 Q2	$17.1M	Buy	+151,603	New	+$16.9M	0.42%	21

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Comgest Global Investors's CBPO Position: Q4 2018 in Review

Comgest Global Investors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2018, closing a stake of 21,026 shares — an estimated $1.68M sold.

Comgest Global Investors first reported a position in CBPO in Q2 2017 and held it in 6 quarters. The position peaked at $51.7M in Q1 2018. 67 funds tracked by Wall St. Rank hold CBPO as of Q4 2018.

Comgest Global Investors reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2018 after selling out during the quarter.
Comgest Global Investors sold 21,026 China Biologic Products Holdings, Inc. shares in Q4 2018, an estimated $1.68M.
Comgest Global Investors first reported a position in China Biologic Products Holdings, Inc. in Q2 2017 and held it in 6 quarters.
Comgest Global Investors's China Biologic Products Holdings, Inc. position peaked at $51.7M in Q1 2018.
67 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2018.

Based on Comgest Global Investors's 13F filing for Q4 2018, filed 12 Feb 2019.